Biovac

South Africa · 460 Employees
Biovac was founded in 2003 to revive and restore South Africa's vaccine manufacturing capabilities. We are an African based manufacturer contributing towards filling the gap that exists in the lack of African vaccine manufacturing capability. We recognise that we'll only achieve this if we match scientific innovation through local biotechnology skills with the most advanced manufacturing technology and global partnerships. We work closely with local academic institutions, global pharmaceutical companies, the public sector as well as private sector. Some of our achievements are described below: We manufacture highly advanced vaccines on behalf of leading international biopharmaceutical companies. Biovac is licensed to manufacture a fully liquid hexavalent vaccine from Sanofi that targets and protects against six childhood diseases. In 2021, we envisage to start the manufacture of a multivalent pneumococcal conjugate vaccine from Pfizer. We supply over 15-million doses of vaccines a year in South Africa and neighbouring countries under strict cold chain conditions. We have built inhouse product development capability and technologies and have successfully out-licensed one of our technologies to international manufacturers. We are working to establish new safeguards against pathogens like group B streptococcus bacteria, a rising cause of sepsis and meningitis in newborns. To do this vital work, we rely on sophisticated technology and, above all, the skills and dedication of more than 350 highly trained team members. Along with our partners, we've invested over R800 million in infrastructure and skills development at our manufacturing facilities in Cape Town. These investments are resulting in estimated benefits of more than R500-million a year to the national economy.

概述

国家 South Africa
成立时间 2003
总部 15 Alexandra Road, Pinelands, Cape Town, Western Cape ZA
电话号码 +27 21 514 5000
网站 http://www.biovac.co.za
LinkedIn http://www.linkedin.com/company/the-biovac-institute
Twitter
Facebook
员工数 460
行业 pharmaceuticals,
简介 Biovac was founded in 2003 to revive and restore South Africa's vaccine manufacturing capabilities. We are an African based manufacturer contributing towards filling the gap that exists in the lack of African vaccine manufacturing capability. We recognise that we'll only achieve this if we match scientific innovation through local biotechnology skills with the most advanced manufacturing technology and global partnerships. We work closely with local academic institutions, global pharmaceutical companies, the public sector as well as private sector. Some of our achievements are described below: We manufacture highly advanced vaccines on behalf of leading international biopharmaceutical companies. Biovac is licensed to manufacture a fully liquid hexavalent vaccine from Sanofi that targets and protects against six childhood diseases. In 2021, we envisage to start the manufacture of a multivalent pneumococcal conjugate vaccine from Pfizer. We supply over 15-million doses of vaccines a year in South Africa and neighbouring countries under strict cold chain conditions. We have built inhouse product development capability and technologies and have successfully out-licensed one of our technologies to international manufacturers. We are working to establish new safeguards against pathogens like group B streptococcus bacteria, a rising cause of sepsis and meningitis in newborns. To do this vital work, we rely on sophisticated technology and, above all, the skills and dedication of more than 350 highly trained team members. Along with our partners, we've invested over R800 million in infrastructure and skills development at our manufacturing facilities in Cape Town. These investments are resulting in estimated benefits of more than R500-million a year to the national economy.

技术

Apache

Load Balancers

Facebook Login (Connect)

Social Login

Facebook Widget

Widgets

Google Font API

Fonts

Microsoft Office 365

Other

Mimecast

Email Providers

Mobile Friendly

Other

Outlook

Email Providers

WordPress.org

CMS

常见问题

Biovac 在哪里?

Biovac 的总部位于 15 Alexandra Road, Pinelands, Cape Town, Western Cape ZA

Biovac 的电话号码是多少?

Biovac 的电话号码是 +27 21 514 5000

Biovac 的官方网站是什么?

Biovac 的公司官方网站是 http://www.biovac.co.za

Biovac 是做什么的?

Biovac 的业务有哪些?

sterile vaccine manufacturing,quality control testing,viewing,labeling,packaging,public sector collaboration,cold chain distribution

Biovac 的年收入是多少?

Biovac 的收入是 0美元

Biovac 有多少员工?

Biovac 有 460 名员工

Biovac 属于哪个行业?

Biovac 从事以下行业: pharmaceuticals

Biovac 使用什么技术?

Biovac 使用的一些流行技术包括: Apache,Facebook Login (Connect),Facebook Widget,Google Font API,Microsoft Office 365,Mimecast,Mobile Friendly,Outlook,WordPress.org

如何联系 Biovac?

Biovac 联系信息: 电话号码:+27 21 514 5000, 网站:http://www.biovac.co.za, 邮箱:gra***@***.***.za

Biovac 的社交媒体链接是什么?

Biovac 领英:http://www.linkedin.com/company/the-biovac-institute,fackbook:,twitte:

Biovac 是一家上市公司吗?

不是

Biovac 的最后一轮融资是什么时候?

暂无最近投资信息

谁投资 Biovac?

Biovac 有 0 家投资者,包括 。

管理层

Graham Forbes

Financial Planning and Analysis Manager

Genevieve Keshwar

Business Development Manager

Maryna Adams

Inventory and systems SAP Supervisor

Saarla Naidoo

Senior QA Outsource Management

员工

Angelo Tsihlas

Chief Quality Officer

Quaanitah Slemming

Personal Assistant : Operations Dept.(Reporting to the Chief Operations Officer)

Enid Rodkin

Personal Assistant / Wellness Co-ordinator

外贸获客 查找关键决策人

10亿+海关交易数据,1.2亿企业数据,2亿+企业联系人数据,1000千万真实采购商。覆盖200+个国家及地区,95%外贸重点拓展市场,可根据行业、经营范围等多方位挖掘目标客户。
免费试用

Top-ranked on G2 Crowd

全球B2B企业库 海关贸易数据 展会采购数据

工作更少,成就更大,销售更聪明

查找更多 B2B 联系人,丰富并验证记录
Email Address

全球B2B企业库

海关贸易数据

展会采购数据

Top-ranked on G2 Crowd

OR
Sign Up with Google